Royal Bank of Canadahttps://www.rbcroyalbank.com/personal.htmlhttps://www.rbcroyalbank.com/personal.htmlInsights1200630enCA
Datum[@Name='Source DCR']
2020-05-26New business models emergeWill genetics usher in a new era of healthcare? Is the entire health ecosystem ready for reinvention? Can digital healthcare in life sciences exceed patient expectations?Expanding Ecosystems3/assets/rbccm/images/gib/healthcare/article_3_thumbnail_sm.jpg/assets/rbccm/images/gib/healthcare/article_3_thumbnail.jpg<h3>Shifting Paradigms</h3>
<p>As the convergence of healthcare and technology has accelerated, new business models are rapidly emerging. </p>
<p>In the traditional biopharma model, the customer would be a physician, R&D tools would be chemical or biological, the end product a pill or vial, and the competitors pharma and biotech players.</p>
<p>The digital revolution in healthcare is shifting this long-established paradigm. Today, biopharma companies’ customer groups have grown to include patients of all ages, providers and payers—all equipped with smartphones and apps that generate a vast amount of digital information to empower their decision-making. R&D has added genetic information and digital capability to its toolset. The end product has broadened beyond the pill to include health outcomes enabled by digital devices and therapeutics. And the competitive set has seen the addition of technology players, including consumer-focused apps and online services, as well as digital health and digital therapeutics firms.</p>
<p class="photo-frame text-center"><img style="width: 100%;" src="/assets/rbccm/images/gib/healthcare/Healthcare-Article-3-Graph-1.png" alt="" /></p>
<h3>A Changing Ecosystem</h3>
<p>Indeed, digital and AI applications are radically changing key areas of the biopharma ecosystem and how patients manage their healthcare.</p>
<p>In pre-clinical research, technology is enabling everything from a deeper mining of literature, to predictive modeling and gene-function annotation. Digital apps are simulating molecular dynamics and pushing the limits of cellular imaging.</p>
<p>In clinical trials, digital transformation is helping to automate testing procedures, build global patient databases and collect real-world data.</p>
<p>In diagnostics, tech powers digital pathology, home-based body diagnosis, and computational analysis of tissue arrays. Just like your car leaves the factory with hundreds of sensors that can trigger the check engine light, humans will have wearable and/or implantable sensors to alert them when something is not functioning properly. Another burgeoning area is immune cell monitoring and digital analysis through just a finger prick.</p>
<p>At the point of patient care, digital applications are already delivering virtual consultations, remote monitoring, VR-based cognitive therapy and digital Rx. Demand for telehealth services and health-based social platforms is also increasing and especially vital in a world facing new challenges such as the COVID-19 pandemic.</p>
<p><img src="/assets/rbccm/images/gib/healthcare/healthcare-article-3-graph-2.png" alt="AI and Digital applications are changing key areas of the Healthcare Ecosystem" /></p>
<div id="similar-to-this" style="border-top: 2px #E6E6E7 dotted; border-bottom: 2px #E6E6E7 dotted; margin: 35px 0; padding: 25px;">
<h4 style="font-size: 18px; letter-spacing: 0.5px; border-bottom: 3px #FEDF01 solid; padding: 0 0 8px 0; margin-bottom: 15px;">Similar to this</h4>
</div>
<h3>Digital Transformation</h3>
<p>The digital revolution presents both threats and opportunities to incumbent biopharma companies. Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities from treatment to prevention.</p>
<div class="quotebox">
<p>“Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities.”</p>
<p class="attribution" style="color: #0070a3;">– Greg Wiederrecht, Ph.D.</p>
<div class="quote-share">
<p style="display: inline-block;"><span style="margin-right: 15px;">Share </span><a class="blue-circle-outline-sm" href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New%20healthcare%20business%20models%20emerge&source=www.rbccm.com" target="_blank" rel="noopener" aria-label="Connect by LinkedIn"><em class="fa fa-linkedin" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="https://twitter.com/home?status=New%20business%20models%20emerge%20https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge" target="_blank" rel="noopener" aria-label="Connect by X"><em class="fa fa-twitter" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="mailto:?subject=New%20business%20models%20emerge&body=I%20found%20this%20insights%20piece%20from%20RBC%20Capital%20Markets%20informative%20and%20thought%20it%20might%20be%20of%20interest%20to%20you%3A%0D%0Dhttps%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New business models emerge" aria-label="Connect by Email"><em class="fa fa-envelope" style="color: #0051a5; margin-left: 3px;"> </em></a></p>
</div>
</div>
<p> </p>
<p>The increased digitization of human experiences gives access to a wealth of information and knowledge that could help intervene before disease has a chance to strike. A prime example of this is collating data from an Apple Watch to screen for irregular heart rhythms and detect undiagnosed atrial fibrillation. At the other end of the spectrum, digital transformation allows a completely new class of therapies such as digital therapeutics to support specific disorders.</p>
<p>McKinsey and Company’s international survey shows that more than 75% of patients expect to use digital healthcare services in the future.<sup>1</sup> Patients are seeking technology that delivers a level of care they can rely on and trust. Ultimately, the aim of the digital revolution is to develop healthier societies and lower the cost of care.</p>
<p style="word-wrap: break-word;"><sup>1 Source: McKinsey and Company, Healthcare’s Digital Future, July 2014. https://www.mckinsey.com/~/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/Healthcares%20digital%20future/Healthcares%20digital%20future.ashx</sup></p><ul>
<li>Customer groups, R&D and competitors are all rapidly expanding</li>
<li>Tech is reinventing every facet of the biopharma ecosystem</li>
<li>Innovations in patient care is driving adoption of digital services</li>
</ul>text2 min1 minHealthcare Models, Digital Healthcare, Digital Healthcare Apps, Digital Health Diagnostics, Expanding R&D, Healthcare & Tech Convergence, Healthcare Services, Clinical Trials, Remote Patient Monitoring, Digital Therapeutics, Biopharma ecosystem, Cost of CareN/templatedata/rbccm/episode/data/healthcare/amazon_cvs_and_google_healthcare_reimagined/templatedata/rbccm/episode/data/healthcare/big_tech_vs_big_pharma/templatedata/rbccm/episode/data/healthcare/the_healthcare_data_explosionGreg Wiederrecht, Ph.D./assets/rbccm/images/gib/healthcare/greg-wiederrecht.jpgManaging Director, Healthcare Investment Bankinggreg.wiederrecht@rbccm.comhttps://www.linkedin.com/in/gregwiederrecht/Sasson Darwish/assets/rbccm/images/gib/healthcare/sasson-darwish.jpgManaging Director, AI, Analytics and IoT & Israel Country Coverage, Global Technology Investment Bankingsasson.darwish@rbccm.com https://www.linkedin.com/in/sassdarwish/Andrew Callaway/assets/rbccm/images/gib/healthcare/andrew-callaway.jpgManaging Director, Global Head of Healthcare Investment Bankingandrew.callaway@rbccm.comhttps://www.linkedin.com/in/andrew-cal-callaway
DEBUG: DCR
DCR
Royal Bank of Canadahttps://www.rbcroyalbank.com/personal.htmlhttps://www.rbcroyalbank.com/personal.htmlInsights1200630enCA
DCR
2020-05-26New business models emergeWill genetics usher in a new era of healthcare? Is the entire health ecosystem ready for reinvention? Can digital healthcare in life sciences exceed patient expectations?Expanding Ecosystems3/assets/rbccm/images/gib/healthcare/article_3_thumbnail_sm.jpg/assets/rbccm/images/gib/healthcare/article_3_thumbnail.jpg<h3>Shifting Paradigms</h3>
<p>As the convergence of healthcare and technology has accelerated, new business models are rapidly emerging. </p>
<p>In the traditional biopharma model, the customer would be a physician, R&D tools would be chemical or biological, the end product a pill or vial, and the competitors pharma and biotech players.</p>
<p>The digital revolution in healthcare is shifting this long-established paradigm. Today, biopharma companies’ customer groups have grown to include patients of all ages, providers and payers—all equipped with smartphones and apps that generate a vast amount of digital information to empower their decision-making. R&D has added genetic information and digital capability to its toolset. The end product has broadened beyond the pill to include health outcomes enabled by digital devices and therapeutics. And the competitive set has seen the addition of technology players, including consumer-focused apps and online services, as well as digital health and digital therapeutics firms.</p>
<p class="photo-frame text-center"><img style="width: 100%;" src="/assets/rbccm/images/gib/healthcare/Healthcare-Article-3-Graph-1.png" alt="" /></p>
<h3>A Changing Ecosystem</h3>
<p>Indeed, digital and AI applications are radically changing key areas of the biopharma ecosystem and how patients manage their healthcare.</p>
<p>In pre-clinical research, technology is enabling everything from a deeper mining of literature, to predictive modeling and gene-function annotation. Digital apps are simulating molecular dynamics and pushing the limits of cellular imaging.</p>
<p>In clinical trials, digital transformation is helping to automate testing procedures, build global patient databases and collect real-world data.</p>
<p>In diagnostics, tech powers digital pathology, home-based body diagnosis, and computational analysis of tissue arrays. Just like your car leaves the factory with hundreds of sensors that can trigger the check engine light, humans will have wearable and/or implantable sensors to alert them when something is not functioning properly. Another burgeoning area is immune cell monitoring and digital analysis through just a finger prick.</p>
<p>At the point of patient care, digital applications are already delivering virtual consultations, remote monitoring, VR-based cognitive therapy and digital Rx. Demand for telehealth services and health-based social platforms is also increasing and especially vital in a world facing new challenges such as the COVID-19 pandemic.</p>
<p><img src="/assets/rbccm/images/gib/healthcare/healthcare-article-3-graph-2.png" alt="AI and Digital applications are changing key areas of the Healthcare Ecosystem" /></p>
<div id="similar-to-this" style="border-top: 2px #E6E6E7 dotted; border-bottom: 2px #E6E6E7 dotted; margin: 35px 0; padding: 25px;">
<h4 style="font-size: 18px; letter-spacing: 0.5px; border-bottom: 3px #FEDF01 solid; padding: 0 0 8px 0; margin-bottom: 15px;">Similar to this</h4>
</div>
<h3>Digital Transformation</h3>
<p>The digital revolution presents both threats and opportunities to incumbent biopharma companies. Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities from treatment to prevention.</p>
<div class="quotebox">
<p>“Tech is powering efficiencies in all stages of the current ecosystem and is also enabling healthcare providers to expand their capabilities.”</p>
<p class="attribution" style="color: #0070a3;">– Greg Wiederrecht, Ph.D.</p>
<div class="quote-share">
<p style="display: inline-block;"><span style="margin-right: 15px;">Share </span><a class="blue-circle-outline-sm" href="https://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New%20healthcare%20business%20models%20emerge&source=www.rbccm.com" target="_blank" rel="noopener" aria-label="Connect by LinkedIn"><em class="fa fa-linkedin" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="https://twitter.com/home?status=New%20business%20models%20emerge%20https%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge" target="_blank" rel="noopener" aria-label="Connect by X"><em class="fa fa-twitter" style="color: #0051a5; margin-left: 3px;"> </em></a> <a class="blue-circle-outline-sm" href="mailto:?subject=New%20business%20models%20emerge&body=I%20found%20this%20insights%20piece%20from%20RBC%20Capital%20Markets%20informative%20and%20thought%20it%20might%20be%20of%20interest%20to%20you%3A%0D%0Dhttps%3A//www.rbccm.com/en/gib/healthcare/episode/new_healthcare_business_models_emerge&title=New business models emerge" aria-label="Connect by Email"><em class="fa fa-envelope" style="color: #0051a5; margin-left: 3px;"> </em></a></p>
</div>
</div>
<p> </p>
<p>The increased digitization of human experiences gives access to a wealth of information and knowledge that could help intervene before disease has a chance to strike. A prime example of this is collating data from an Apple Watch to screen for irregular heart rhythms and detect undiagnosed atrial fibrillation. At the other end of the spectrum, digital transformation allows a completely new class of therapies such as digital therapeutics to support specific disorders.</p>
<p>McKinsey and Company’s international survey shows that more than 75% of patients expect to use digital healthcare services in the future.<sup>1</sup> Patients are seeking technology that delivers a level of care they can rely on and trust. Ultimately, the aim of the digital revolution is to develop healthier societies and lower the cost of care.</p>
<p style="word-wrap: break-word;"><sup>1 Source: McKinsey and Company, Healthcare’s Digital Future, July 2014. https://www.mckinsey.com/~/media/McKinsey/Industries/Healthcare%20Systems%20and%20Services/Our%20Insights/Healthcares%20digital%20future/Healthcares%20digital%20future.ashx</sup></p><ul>
<li>Customer groups, R&D and competitors are all rapidly expanding</li>
<li>Tech is reinventing every facet of the biopharma ecosystem</li>
<li>Innovations in patient care is driving adoption of digital services</li>
</ul>text2 min1 minHealthcare Models, Digital Healthcare, Digital Healthcare Apps, Digital Health Diagnostics, Expanding R&D, Healthcare & Tech Convergence, Healthcare Services, Clinical Trials, Remote Patient Monitoring, Digital Therapeutics, Biopharma ecosystem, Cost of CareN/templatedata/rbccm/episode/data/healthcare/amazon_cvs_and_google_healthcare_reimagined/templatedata/rbccm/episode/data/healthcare/big_tech_vs_big_pharma/templatedata/rbccm/episode/data/healthcare/the_healthcare_data_explosionGreg Wiederrecht, Ph.D./assets/rbccm/images/gib/healthcare/greg-wiederrecht.jpgManaging Director, Healthcare Investment Bankinggreg.wiederrecht@rbccm.comhttps://www.linkedin.com/in/gregwiederrecht/Sasson Darwish/assets/rbccm/images/gib/healthcare/sasson-darwish.jpgManaging Director, AI, Analytics and IoT & Israel Country Coverage, Global Technology Investment Bankingsasson.darwish@rbccm.com https://www.linkedin.com/in/sassdarwish/Andrew Callaway/assets/rbccm/images/gib/healthcare/andrew-callaway.jpgManaging Director, Global Head of Healthcare Investment Bankingandrew.callaway@rbccm.comhttps://www.linkedin.com/in/andrew-cal-callaway
12025-05-22Highlights from RBC Capital Markets' Sustainable Debt SymposiumKey themes include sustainable bond market resilience, Indigenous financing, addressing risks like greenwashing, and prioritizing issuers' sustainability strategies.noneInsightsHome | Insights/assets/rbccm/images/insights/2025/20250508-key-takeaways-th.webp/assets/rbccm/images/insights/2025/20250508-key-takeaways-banner.jpghttps://www.rbccm.com/en/story/story.page?dcr=templatedata/article/story/data/2025/05/sustainable-debt-conference-key-takeawaysnone<p>On April 9<sup>th</sup>, RBC Capital Markets hosted its 12<sup>th</sup> annual Sustainable Debt Conference amidst market volatility, political uncertainty, heightened legal and regulatory scrutiny, and increased polarization of ESG. The event aimed to assess the impact of these dynamics on the sustainable debt market, explore emerging themes, and highlight opportunities for growth and innovation. Key highlights include:</p>
<h2 style="font-size: 25px;">1. Sustainable bond issuance holds steady in 2025</h2>
<ul>
<li><strong>Global trends:</strong> Global sustainable bond issuance is projected to total $1 trillion in 2025, in line with 2024. <sup><a title="Link to Footnotes" href="#footnote" name="_ftnref1">[1]</a></sup> Social bonds will face challenges due to a lack of benchmark-sized projects, while transition-labeled bonds and sustainability-linked bonds (SLBs) will remain niche segments amid evolving market sentiment.</li>
<li><strong>Regional divergence:</strong> Europe will continue to lead in sustainable bond issuance, while the US is expected to decline further. Canada will be a market to watch, given stable volumes in 2024, driven primarily by green bonds.</li>
<li><strong>Use of proceeds:</strong> Climate mitigation remains the primary focus for sustainable bond proceeds, but adaptation and nature-related projects are steadily scaling.</li>
</ul>
<h2 style="font-size: 25px;">2. Sustainable investing under Trump 2.0</h2>
<ul>
<li><strong>Resilient fixed income: </strong>Sustainable fixed income funds have seen persistent inflows, and their share of total fixed income fund assets under management (AUM) remains near all-time highs. This resilience is partly due to more patient capital and reduced greenwashing risks in sustainable use of proceeds bonds.</li>
<li><strong>High-performing investment themes:</strong> Investment themes such as sustainable forestry, water, agriculture, food, and green buildings have outperformed amid market volatility.</li>
<li><strong>Focus areas:</strong> Finally, investors are closely monitoring developments related to Diversity, Equity, and Inclusion (DEI) in the US, and sustainable fund exclusions related to defense, given heightened geopolitical risks.</li>
</ul>
<h2 style="font-size: 25px;">3. Indigenous Finance and Sustainable Bond Principles</h2>
<ul>
<li><strong>Funding gap:</strong> Indigenous communities in Canada face a C$300-500bn funding gap in housing, infrastructure, and economic development, with unaffordable and uneven access to capital.<sup><a title="Link to Footnotes" href="#footnote" name="_ftnref2">[2]</a></sup></li>
<li><strong>Challenges:</strong> While Canadian investors, corporates, and governments are eager to advance economic reconciliation, the lack of standards for Indigenous-focused investments can pose a risk of “redwashing”.</li>
<li><strong>Opportunities: </strong>The Green and Social Bond Principles offer a framework to mobilize capital, promote transparency and disclosure, systematically embed Indigenous-related considerations into bond programs, and measure impact from the allocation of proceeds.</li>
</ul>
<h2 style="font-size: 25px;">4. Greenhushing is not the answer</h2>
<ul>
<li><strong>Increased scrutiny: </strong>External scrutiny of corporate climate initiatives has increased significantly in recent months, with a proliferation of greenwashing enforcement and new laws, including the amendments to Canada’s Competition Act through Bill C-59.</li>
<li><strong>Risks: </strong>Companies risk being accused of greenhushing by saying too little or greenwashing by saying too much.</li>
<li><strong>Solutions:</strong> Practical measures to avoid these risks while advancing sustainability efforts include updating environmental marketing materials, substantiating environmental claims, training employees, and conducting compliance audits.</li>
</ul>
<h2 style="font-size: 25px;">5. Sustainable bond labels: nice to have, not essential</h2>
<ul>
<li><strong>Beyond labels: </strong>Investors are increasingly prioritizing issuers’ sustainability strategies and performance over bond labels. In addition, Second Party Opinion providers are increasingly integrating issuer-level analysis into their assessments.</li>
<li><strong>Transition finance:</strong> Investors are eager to fund decarbonization projects for issuers with credible transition plans, regardless of the bond label. In the absence of a Canadian transition finance taxonomy, investors are relying on internal methodologies and third-party data to assess opportunities.</li>
<li><strong>Innovative structures:</strong> Investors are also open to innovative structures, including outcome-based bonds such as the World Bank Wildlife Conservation Bond, which finances conservation efforts.</li>
</ul>
<p id="footnote"></p>
<p>Despite market headwinds, it was clear from the discussions at RBC Capital Markets’ Sustainable Debt Conference that fixed income investors remain committed to sustainable investing, while existing issuers remain committed to their sustainable bond programs. The challenge lies in growing issuance volumes, incentivizing new issuers, and fostering innovation amid volatility and polarization. Ongoing dialogue among investors, issuers, intermediaries, and service providers will be critical to advancing the transition to a sustainable and resilient economy.</p>
<div class="footnotes"><hr>
<p style="margin-top: 25px; margin-bottom: 0;"><a class="collapse-toggle collapsed" title="Footnotes" href="#articleFootnote" data-toggle="collapse" aria-expanded="false"> + Footnotes </a></p>
<div id="articleFootnote" class="collapse-content collapse" style="height: 0px;" aria-expanded="false">
<div class="collapse-inner">
<p class="small" style="padding-top: 25px;"><a title="Link to RBC Capital Markets Global Sustainability Strategy Research" href="#_ftnref1" name="_ftn1">[1]</a><a title="Link to ESG Today article" href="https://www.esgtoday.com/moodys-predicts-1-trillion-sustainable-bond-market-in-2025-despite-political-headwinds/" target="_blank" rel="noopener">https://www.esgtoday.com/moodys-predicts-1-trillion-sustainable-bond-market-in-2025-despite-political-headwinds/</a><br><a title="Link to BloombergNEF" href="#_ftnref2" name="_ftn2">[2]</a><a title="Link to AFN article" href="https://afn.ca/economy-infrastructure/infrastructure/closing-the-infrastructure-gap/#:%7E:text=FAQs,close%20these%20disparities%20by%202030" target="_blank" rel="noopener">https://afn.ca/economy-infrastructure/infrastructure/closing-the-infrastructure-gap/</a></p>
</div>
</div>
</div>Disclaimer<p class="small">This article is provided for information purposes only. This article may contain forward-looking statements of Royal Bank of Canada (“RBC”) or its affiliates within the meaning of certain securities laws. Information in this article is or may be based on assumptions, estimates and judgements. All expressions of opinion in this article reflect the judgment of the authors as of the date of publication and are subject to change. For cautionary statements relating to the information in this article, refer to the “Important Notice Regarding Information on this Website and Caution Regarding Forward-Looking Statements” section on RBC Capital Markets’ Sustainable Finance webpage, available at <a title="Link to RBC Sustainable Finance page" href="https://www.rbccm.com/en/expertise/sustainable-finance.page" target="_blank" rel="noreferrer noopener">https://www.rbccm.com/en/expertise/sustainable-finance.page</a>. Except as required by law, none of RBC nor any of its affiliates undertake to update any information in this article.</p>text2 minenglobalOur expert1/templatedata/rbccm/authors/data/sarah-thompsonsarah-thompsonSarah ThompsonGlobal Head, Sustainable Finance, RBC Capital MarketsN/assets/rbccm/images/authors/sarah-thompson.pngsarah.e.thompson@rbccm.com<p>As part of the Sustainable Finance Group, Sarah works closely with the growing number of corporate and institutional clients globally who view Environmental, Social and Governance (ESG) factors as important considerations in their corporate strategy and investment decision-making process.</p>
<p>Sarah joined RBC in 2011 as the bank’s first Green IT Manager. In 2013, she moved to RBC’s Corporate Sustainability Team to oversee enterprise-wide operational footprint reduction initiatives, produce ESG disclosure and support business units with the development of sustainable financial products and services. In addition, Sarah partnered with RBC’s Corporate Treasury Group to establish RBC’s Green Bond Program. The bank issued its inaugural Green Bond in April 2019 following the publication of its Green Bond Framework outlining the process for Green Bond issuance and reporting.</p>
<p>Sarah represents RBC Capital Markets on the Advisory Council of the Green and Social Bond Principles Executive Committee and is Vice Chair of the CSA Group Green & Transition Finance Technical Committee.</p>
<p>Sarah is based in Toronto, Canada. She holds a Bachelor of Commerce in Economics from McGill University and an MBA in Sustainability from York University’s Schulich School of Business.</p>By <strong>Sarah Thompson, RBC Capital Markets</strong> By <strong>Sarah Thompson, RBC Capital Markets</strong> 1/templatedata/article/story/data/2025/02/2025-global-esg-fixed-income-investor-survey-results/templatedata/article/story/data/2025/03/navigating-a-rapidly-evolving-sustainable-finance-landscape/templatedata/article/story/data/2025/04/future-proofing-real-estate-for-a-changing-climateinsights, esg stratifyKey themes include sustainable bond market resilience, Indigenous financing, addressing risks like greenwashing, and prioritizing issuers' sustainability strategies.sustainable finance, sustainable debt, sustainable investing, sustainable bondsSustainable Finance, Sustainable Debt
Highlights from RBC Capital Markets' Sustainable Debt Symposium
Key themes include sustainable bond market resilience, Indigenous financing, addressing risks like greenwashing, and prioritizing issuers' sustainability strategies.
By Sarah Thompson, RBC Capital Markets Published | 2 min
read
On April 9th, RBC Capital Markets hosted its 12th annual Sustainable Debt Conference amidst market volatility, political uncertainty, heightened legal and regulatory scrutiny, and increased polarization of ESG. The event aimed to assess the impact of these dynamics on the sustainable debt market, explore emerging themes, and highlight opportunities for growth and innovation. Key highlights include:
1. Sustainable bond issuance holds steady in 2025
Global trends: Global sustainable bond issuance is projected to total $1 trillion in 2025, in line with 2024. [1] Social bonds will face challenges due to a lack of benchmark-sized projects, while transition-labeled bonds and sustainability-linked bonds (SLBs) will remain niche segments amid evolving market sentiment.
Regional divergence: Europe will continue to lead in sustainable bond issuance, while the US is expected to decline further. Canada will be a market to watch, given stable volumes in 2024, driven primarily by green bonds.
Use of proceeds: Climate mitigation remains the primary focus for sustainable bond proceeds, but adaptation and nature-related projects are steadily scaling.
2. Sustainable investing under Trump 2.0
Resilient fixed income: Sustainable fixed income funds have seen persistent inflows, and their share of total fixed income fund assets under management (AUM) remains near all-time highs. This resilience is partly due to more patient capital and reduced greenwashing risks in sustainable use of proceeds bonds.
High-performing investment themes: Investment themes such as sustainable forestry, water, agriculture, food, and green buildings have outperformed amid market volatility.
Focus areas: Finally, investors are closely monitoring developments related to Diversity, Equity, and Inclusion (DEI) in the US, and sustainable fund exclusions related to defense, given heightened geopolitical risks.
3. Indigenous Finance and Sustainable Bond Principles
Funding gap: Indigenous communities in Canada face a C$300-500bn funding gap in housing, infrastructure, and economic development, with unaffordable and uneven access to capital.[2]
Challenges: While Canadian investors, corporates, and governments are eager to advance economic reconciliation, the lack of standards for Indigenous-focused investments can pose a risk of “redwashing”.
Opportunities: The Green and Social Bond Principles offer a framework to mobilize capital, promote transparency and disclosure, systematically embed Indigenous-related considerations into bond programs, and measure impact from the allocation of proceeds.
4. Greenhushing is not the answer
Increased scrutiny: External scrutiny of corporate climate initiatives has increased significantly in recent months, with a proliferation of greenwashing enforcement and new laws, including the amendments to Canada’s Competition Act through Bill C-59.
Risks: Companies risk being accused of greenhushing by saying too little or greenwashing by saying too much.
Solutions: Practical measures to avoid these risks while advancing sustainability efforts include updating environmental marketing materials, substantiating environmental claims, training employees, and conducting compliance audits.
5. Sustainable bond labels: nice to have, not essential
Beyond labels: Investors are increasingly prioritizing issuers’ sustainability strategies and performance over bond labels. In addition, Second Party Opinion providers are increasingly integrating issuer-level analysis into their assessments.
Transition finance: Investors are eager to fund decarbonization projects for issuers with credible transition plans, regardless of the bond label. In the absence of a Canadian transition finance taxonomy, investors are relying on internal methodologies and third-party data to assess opportunities.
Innovative structures: Investors are also open to innovative structures, including outcome-based bonds such as the World Bank Wildlife Conservation Bond, which finances conservation efforts.
Despite market headwinds, it was clear from the discussions at RBC Capital Markets’ Sustainable Debt Conference that fixed income investors remain committed to sustainable investing, while existing issuers remain committed to their sustainable bond programs. The challenge lies in growing issuance volumes, incentivizing new issuers, and fostering innovation amid volatility and polarization. Ongoing dialogue among investors, issuers, intermediaries, and service providers will be critical to advancing the transition to a sustainable and resilient economy.
This article is provided for information purposes only. This article may contain forward-looking statements of Royal Bank of Canada (“RBC”) or its affiliates within the meaning of certain securities laws. Information in this article is or may be based on assumptions, estimates and judgements. All expressions of opinion in this article reflect the judgment of the authors as of the date of publication and are subject to change. For cautionary statements relating to the information in this article, refer to the “Important Notice Regarding Information on this Website and Caution Regarding Forward-Looking Statements” section on RBC Capital Markets’ Sustainable Finance webpage, available at https://www.rbccm.com/en/expertise/sustainable-finance.page. Except as required by law, none of RBC nor any of its affiliates undertake to update any information in this article.
Related content
Our expert
Sarah Thompson
Global Head, Sustainable Finance, RBC Capital Markets
More insights
Stay informed
Get the latest insights and news from RBC Capital Markets delivered to your inbox.